ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
23K |
8.1M |
5 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
23K
|
8.1M
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Positive topline results from SAR-bisPSMA diagnostic trial
|
|
tonks306511
|
17 |
9.9K |
2 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
17
|
9.9K
|
2
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Strong Results From Tumas Definitive Feasibility Study
|
|
tonks306511
|
46 |
24K |
0 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Strong Results From Tumas Definitive Feasibility Study
|
|
tonks306511
|
46 |
24K |
0 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Strong Results From Tumas Definitive Feasibility Study
|
|
tonks306511
|
46 |
24K |
0 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Strong Results From Tumas Definitive Feasibility Study
|
|
tonks306511
|
46 |
24K |
3 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
46
|
24K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
12K |
4.2M |
0 |
01/02/23 |
01/02/23 |
General
|
12K
|
4.2M
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
tonks306511
|
56 |
16K |
2 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
56
|
16K
|
2
|
|
ASX - By Stock
|
PH2 |
Re:
Ann: December 2022 Quarterly Report
|
|
tonks306511
|
4 |
2.6K |
8 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
4
|
2.6K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
tonks306511
|
56 |
16K |
27 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
56
|
16K
|
27
|
|
ASX - By Stock
|
HIO |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
tonks306511
|
11 |
5.1K |
4 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
11
|
5.1K
|
4
|
|
ASX - By Stock
|
DYL |
Re:
Uranium the next Lithium
|
|
tonks306511
|
19 |
11K |
5 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
19
|
11K
|
5
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
12K |
4.2M |
9 |
24/01/23 |
24/01/23 |
General
|
12K
|
4.2M
|
9
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
12K |
4.2M |
3 |
22/01/23 |
22/01/23 |
General
|
12K
|
4.2M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders, Notice of Meeting & Proxy Form
|
|
tonks306511
|
41 |
13K |
25 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
41
|
13K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders, Notice of Meeting & Proxy Form
|
|
tonks306511
|
41 |
13K |
25 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
41
|
13K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders, Notice of Meeting & Proxy Form
|
|
tonks306511
|
41 |
13K |
12 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
41
|
13K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y - Dr Daniel Tillett
|
|
tonks306511
|
46 |
16K |
22 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
46
|
16K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
tonks306511
|
2.5K |
857K |
7 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
2.5K
|
857K
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
23K |
8.1M |
26 |
08/01/23 |
08/01/23 |
ASX - By Stock
|
23K
|
8.1M
|
26
|
|
ASX - By Stock
|
PV1 |
Re:
Provaris - Media
|
|
tonks306511
|
163 |
82K |
3 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
163
|
82K
|
3
|
|
ASX - By Stock
|
HIO |
Re:
Price and Chart HIO
|
|
tonks306511
|
7.4K |
3.0M |
4 |
02/01/23 |
02/01/23 |
ASX - By Stock
|
7.4K
|
3.0M
|
4
|
|
ASX - By Stock
|
PV1 |
Re:
Provaris - Media
|
|
tonks306511
|
163 |
82K |
0 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
163
|
82K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race supports Study of Extramedullary AML
|
|
tonks306511
|
50 |
20K |
2 |
24/12/22 |
24/12/22 |
ASX - By Stock
|
50
|
20K
|
2
|
|
ASX - By Stock
|
PV1 |
Re:
Provaris - Media
|
|
tonks306511
|
163 |
82K |
3 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
163
|
82K
|
3
|
|
ASX - By Stock
|
PV1 |
Re:
Provaris - Media
|
|
tonks306511
|
163 |
82K |
3 |
17/12/22 |
17/12/22 |
ASX - By Stock
|
163
|
82K
|
3
|
|
ASX - By Stock
|
HIO |
Re:
Granzien focus or 1 foot out the door?
|
|
tonks306511
|
43 |
18K |
2 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
43
|
18K
|
2
|
|
ASX - By Stock
|
PH2 |
Re:
Australian Hydrogen Conference 2022
|
|
tonks306511
|
27 |
10K |
1 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
27
|
10K
|
1
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Results of Annual General Meeting
|
|
tonks306511
|
11 |
5.8K |
1 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
11
|
5.8K
|
1
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Results of Annual General Meeting
|
|
tonks306511
|
11 |
5.8K |
0 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
11
|
5.8K
|
0
|
|
ASX - By Stock
|
DYL |
Re:
Ann: Results of Annual General Meeting
|
|
tonks306511
|
11 |
5.8K |
0 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
11
|
5.8K
|
0
|
|
ASX - By Stock
|
HIO |
Re:
Ann: Hawsons Institutional Placement
|
|
tonks306511
|
189 |
75K |
7 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
189
|
75K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race 2022 AGM Presentations
|
|
tonks306511
|
118 |
33K |
5 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
118
|
33K
|
5
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
tonks306511
|
12K |
4.2M |
8 |
22/11/22 |
22/11/22 |
General
|
12K
|
4.2M
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
23K |
8.1M |
19 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
23K
|
8.1M
|
19
|
|
ASX - By Stock
|
PER |
Re:
NOW I UNDERSTAND MARK
|
|
tonks306511
|
15 |
6.2K |
6 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
15
|
6.2K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Results of Annual General Meeting
|
|
tonks306511
|
1 |
1.0K |
4 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
1
|
1.0K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Chief Medical Officer Appointment
|
|
tonks306511
|
94 |
25K |
5 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
94
|
25K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Chief Medical Officer Appointment
|
|
tonks306511
|
94 |
25K |
2 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
94
|
25K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Chief Medical Officer Appointment
|
|
tonks306511
|
94 |
25K |
8 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
94
|
25K
|
8
|
|
ASX - By Stock
|
PV1 |
Re:
Ann: Appendix 3Y - Director's Interest
|
|
tonks306511
|
2 |
1.0K |
2 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
2
|
1.0K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: 50% recruitment reached for Phase II prostate cancer trial
|
|
tonks306511
|
25 |
11K |
1 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
25
|
11K
|
1
|
|
ASX - By Stock
|
PER |
Re:
ANP - Interesting general news items in BIO
|
|
tonks306511
|
125 |
40K |
6 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
125
|
40K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: 50% recruitment reached for Phase II prostate cancer trial
|
|
tonks306511
|
25 |
11K |
3 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
25
|
11K
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
tonks306511
|
23K |
8.1M |
15 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
23K
|
8.1M
|
15
|
|
ASX - By Stock
|
PH2 |
Re:
Ann: September 2022 Quarterly Report
|
|
tonks306511
|
7 |
3.2K |
1 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
7
|
3.2K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Corporate Presentation - Wilsons Drug and Device Conference
|
|
tonks306511
|
2 |
1.2K |
4 |
29/10/22 |
29/10/22 |
ASX - By Stock
|
2
|
1.2K
|
4
|
|
ASX - By Stock
|
DYL |
Re:
It’s started…
|
|
tonks306511
|
44 |
27K |
3 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
44
|
27K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Letter to Shareholders, Notice of AGM & Proxy Form
|
|
tonks306511
|
6 |
3.3K |
15 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
6
|
3.3K
|
15
|
|
ASX - By Stock
|
HIO |
Re:
PROJECT VALUATIONS
|
|
tonks306511
|
86 |
45K |
0 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
86
|
45K
|
0
|
|